Combination Chemotherapy of Gemcitabine and Paclitaxel for Metastatic Breast Cancer

Clinical trial NCT00334802 · COMPLETED

Trial details

NCT number: NCT00334802
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Breast Cancer

Start date: 2006-06-01
Primary completion: 2008-02-01
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.